Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hypotaurine (CAS 300-84-5) Market by Type (Greater than or equal to98%, Others), By Application (Healthy Food, Drink, Feed, Medicine, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hypotaurine (CAS 300-84-5) Market by Type (Greater than or equal to98%, Others), By Application (Healthy Food, Drink, Feed, Medicine, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 145741 3300 Chemical & Material 377 236 Pages 4.7 (32)
                                          

Market Overview:


The global hypotaurine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for healthy food and beverages, increasing awareness about the benefits of hypotaurine, and growing demand from emerging markets. However, stringent regulations governing the use of additives in food products may restrain the growth of this market during the forecast period. On the basis of type, greater than or equal to 98% segment is expected to account for a major share of the global hypotaurine market during 2018-2030. This segment is projected to grow at a CAGR of 6% overthe forecast period due its high purity and superior quality compared with other types available in the market. On th e basis o f application , h ealthy foo d an d drink segm en t i s expec ted t o ac count for th e major share o f th e globa l hy p otaurin e mark et du ri ng 2 018 -2 028 . Thi s segm en t i s projec ted t o gr ow at a CA GR o f 5 % ov erth e fo recas t per iod du es its hig h purit y an d superio r qu alit y co mp ared wi th other typ es availab le in th e mark et .


Global Hypotaurine (CAS 300-84-5) Industry Outlook


Product Definition:


Hypotaurine is a natural amino acid which has been found to be effective in the treatment of anxiety and stress. It is also known to improve cognitive function and memory.


Greater than or equal to98%:


Hypotaurine (CAS 300-84-5) is a colorless and water-soluble organic compound. It has a strong odor similar to that of garlic or rotten eggs. It is soluble in alcohol, ether, acetone and water; however, it is insoluble in benzene and chloroform. Hypotaurine exists as two enantiomers: S-enantiomer and R-enantiomer which are both racemic mixtures.


Others:


Others is a chemical, which is produced by the fermentation of bacteria. It consists of organic compounds and inorganic compounds. The others segment includes products such as alcohols, ketones, lactams & lactates esters (amide), amides & imides (imide), glycolic acid derivatives (glycolic acid and its derivatives), formamidines, fumaric acid esters (fumaric acid and its derivative) acetic acids anhydrides.


Application Insights:


Healthy food, drink, feed and medicine were the major application segments of the global hypotaurine market. Medicine was the largest segment in 2017 owing to extensive usage as an expectorant and cough suppressant. Other applications include its use as a preservative in cosmetics and pharmaceuticals. The other applications are expected to witness growth with increasing demand for cosmetic products across various regions including Asia Pacific, North America, Latin America etc.


The healthy food application is projected to witness significant growth over the forecast period due to rising consumer awareness regarding health benefits associated with it such as antioxidant properties that help reduce aging effects on skin etc. Minotaurine has been used for centuries by different cultures around the world for their religious practices; however there is limited scientific evidence supporting its benefits over traditional medicines or herbs which may be substituted for it instead of medicinal use of hypotaurine among others such as dietary supplements & functional foods among many others (healthy food).


Regional Analysis:


Asia Pacific is expected to be the largest as well as the fastest-growing regional market over the forecast period. The growth can be attributed to increasing product demand in countries, such as China and India. In addition, rising awareness regarding health benefits of hypotaurine coupled with growing population is anticipated to drive industry expansion over the coming years.


Europe accounted for a significant share of global revenue in 2017 owing to high consumption levels of Minotaur in several European countries, including Germany and France. Moreover, presence of major manufacturers across this region will support industry expansion during the forecast period.


Growth Factors:


  • Increasing demand from pharmaceutical and nutraceutical industries for the use of hypotaurine in various formulations
  • Growing research and development activities for the use of hypotaurine in new drug discovery programs
  • Rising awareness about the health benefits of hypotaurine among consumers
  • Increasing investment by manufacturers in production capacity expansion projects
  • Growing export opportunities for hypotaurine products

Scope Of The Report

Report Attributes

Report Details

Report Title

Hypotaurine (CAS 300-84-5) Market Research Report

By Type

Greater than or equal to98%, Others

By Application

Healthy Food, Drink, Feed, Medicine, Other

By Companies

Qianjiang Yongan Pharmaceutical, China Grand Pharmaceutical, Jiangyin Huachang Food Additive, Jiangsu Yuanyang Pharmaceutical, Taisho Pharmaceutical, Kasano Kosan Corporation

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

236

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Hypotaurine (CAS 300-84-5) Market Report Segments:

The global Hypotaurine (CAS 300-84-5) market is segmented on the basis of:

Types

Greater than or equal to98%, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Healthy Food, Drink, Feed, Medicine, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Qianjiang Yongan Pharmaceutical
  2. China Grand Pharmaceutical
  3. Jiangyin Huachang Food Additive
  4. Jiangsu Yuanyang Pharmaceutical
  5. Taisho Pharmaceutical
  6. Kasano Kosan Corporation

Global Hypotaurine (CAS 300-84-5) Market Overview


Highlights of The Hypotaurine (CAS 300-84-5) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Greater than or equal to98%
    2. Others
  1. By Application:

    1. Healthy Food
    2. Drink
    3. Feed
    4. Medicine
    5. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hypotaurine (CAS 300-84-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hypotaurine (CAS 300-84-5) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Hypotaurine (CAS 300-84-5) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Hypotaurine (CAS 300-84-5) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Hypotaurine (CAS 300-84-5) Market - Supply Chain
   4.5. Global Hypotaurine (CAS 300-84-5) Market Forecast
      4.5.1. Hypotaurine (CAS 300-84-5) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Hypotaurine (CAS 300-84-5) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Hypotaurine (CAS 300-84-5) Market Absolute $ Opportunity

5. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      5.3.1. Greater than or equal to98%
      5.3.2. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      6.3.1. Healthy Food
      6.3.2. Drink
      6.3.3. Feed
      6.3.4. Medicine
      6.3.5. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026

9. North America Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      9.4.1. Healthy Food
      9.4.2. Drink
      9.4.3. Feed
      9.4.4. Medicine
      9.4.5. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      9.7.1. Greater than or equal to98%
      9.7.2. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026

10. Latin America Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      10.4.1. Healthy Food
      10.4.2. Drink
      10.4.3. Feed
      10.4.4. Medicine
      10.4.5. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      10.7.1. Greater than or equal to98%
      10.7.2. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026

11. Europe Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      11.4.1. Healthy Food
      11.4.2. Drink
      11.4.3. Feed
      11.4.4. Medicine
      11.4.5. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      11.7.1. Greater than or equal to98%
      11.7.2. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026

12. Asia Pacific Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      12.4.1. Healthy Food
      12.4.2. Drink
      12.4.3. Feed
      12.4.4. Medicine
      12.4.5. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      12.7.1. Greater than or equal to98%
      12.7.2. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026

13. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
      13.4.1. Healthy Food
      13.4.2. Drink
      13.4.3. Feed
      13.4.4. Medicine
      13.4.5. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
      13.7.1. Greater than or equal to98%
      13.7.2. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Hypotaurine (CAS 300-84-5) Market: Market Share Analysis
   14.2. Hypotaurine (CAS 300-84-5) Distributors and Customers
   14.3. Hypotaurine (CAS 300-84-5) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Qianjiang Yongan Pharmaceutical
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. China Grand Pharmaceutical
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Jiangyin Huachang Food Additive
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Jiangsu Yuanyang Pharmaceutical
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Taisho Pharmaceutical
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Kasano Kosan Corporation
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us